Search Results

BTZ043 Racemate 10 mg  | 98.47%

TargetMol

BTZ043 racemate is a decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1) inhibitor, used as a new antimycobacterial agent.

More Information Supplier Page

BTZ043 Racemate 25 mg  | 98.47%

TargetMol

BTZ043 racemate is a decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1) inhibitor, used as a new antimycobacterial agent.

More Information Supplier Page

BV6 5 mg  | Purity Not Available

TargetMol

BV6 is an antagonist of c-IAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.

More Information Supplier Page

BV6 50 mg  | Purity Not Available

TargetMol

BV6 is an antagonist of c-IAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.

More Information Supplier Page

BV6 2 mg  | Purity Not Available

TargetMol

BV6 is an antagonist of c-IAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.

More Information Supplier Page

BV6 10 mg  | Purity Not Available

TargetMol

BV6 is an antagonist of c-IAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.

More Information Supplier Page

BV6 100 mg  | Purity Not Available

TargetMol

BV6 is an antagonist of c-IAP1 and XIAP, members of the inhibitors of apoptosis (IAP) family.

More Information Supplier Page

BTZ043 Racemate 5 mg  | 98.47%

TargetMol

BTZ043 racemate is a decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1) inhibitor, used as a new antimycobacterial agent.

More Information Supplier Page

BTZ043 Racemate 50 mg  | 98.47%

TargetMol

BTZ043 racemate is a decaprenylphosphoryl-β-D-ribose 2′-epimerase (DprE1) inhibitor, used as a new antimycobacterial agent.

More Information Supplier Page